Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
SPECT imaging of striatal dopamine release after amphetamine challenge
M. Laruelle
, A. Abi-Dargham
, C. H. Van Dyck
, W. Rosenblatt
, Y. Zea-Ponce
, S. S. Zoghbi
, R. M. Baldwin
,
D. S. Charney
, P. B. Hoffer
, H. F. Kung
, R. B. Innis
Research output
:
Contribution to journal
›
Article
›
peer-review
318
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'SPECT imaging of striatal dopamine release after amphetamine challenge'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
SPECT Imaging
100%
Amphetamine
100%
Striatal Dopamine Release
100%
Amphetamine Challenge
100%
Single-photon Emission Computed Tomography (SPECT)
33%
D2 Receptor
33%
Dopamine Release
33%
Alertness
33%
Euphoria
33%
Dextroamphetamine Sulfate
33%
Neurochemicals
16%
Behavioral Effects
16%
Striatal
16%
Behavioral Response
16%
Radiotracer
16%
123I
16%
Controlled Experiment
16%
Challenge Test
16%
Anxiety Sensitivity
16%
Self-rating
16%
Bolus Infusion
16%
123I-IBZM
16%
Iodobenzamide
16%
Endogenous Dopamine
16%
Stable Baselines
16%
Administration Schedule
16%
Human Striatum
16%
Infusion Administration
16%
Equilibrium Partition Coefficient
16%
Analog Scale
16%
Biochemistry, Genetics and Molecular Biology
Single Photon Emission Computed Tomography
100%
Dopamine Release
100%
Sulfate
50%
Iodine-123
50%
Euphoria
50%
Dextroamphetamine
50%
Normal Human
25%
Neurochemical
25%
Self Concept
25%
Partition Coefficient
25%
Iodobenzamide
25%
Neuroscience
Single-Photon Emission Computed Tomography
100%
Dopamine Release
100%
Amphetamine
100%
Iodine-123
28%
Euphoria
28%
Dextroamphetamine
28%
Receptor
28%
Behavioral Effect
14%
Striatum
14%
Iodobenzamide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamphetamine
100%
Amphetamine
100%
Tracer
28%
Receptor
28%
Iodine-123
28%
Restlessness
28%
Behavioral Effect
14%
Normal Human
14%
Iolopride
14%
Iodobenzamide
14%